Cite
Evaluating the Significance of Fasting C-peptide in Conjunction with the Insulin Resistance Index for Assessing Hepatic Fibrosis in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
MLA
Huifang Zhou, et al. “Evaluating the Significance of Fasting C-Peptide in Conjunction with the Insulin Resistance Index for Assessing Hepatic Fibrosis in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.” Alternative Therapies in Health & Medicine, vol. 30, no. 11, Nov. 2024, pp. 319–23. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=180999714&authtype=sso&custid=ns315887.
APA
Huifang Zhou, Lihua Han, Yu Wang, Yuanyuan Zhao, Changqian Fang, Xiaogai Zhang, Hailin Li, & Rendong Zheng. (2024). Evaluating the Significance of Fasting C-peptide in Conjunction with the Insulin Resistance Index for Assessing Hepatic Fibrosis in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. Alternative Therapies in Health & Medicine, 30(11), 319–323.
Chicago
Huifang Zhou, Lihua Han, Yu Wang, Yuanyuan Zhao, Changqian Fang, Xiaogai Zhang, Hailin Li, and Rendong Zheng. 2024. “Evaluating the Significance of Fasting C-Peptide in Conjunction with the Insulin Resistance Index for Assessing Hepatic Fibrosis in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.” Alternative Therapies in Health & Medicine 30 (11): 319–23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=180999714&authtype=sso&custid=ns315887.